114 related articles for article (PubMed ID: 21616448)
1. [Innovations in hormonal treatment for locally advanced and/or metastatic prostate cancer].
Audenet F; Rouprêt M; Tombal B
Prog Urol; 2011 May; 21 Suppl 3():S96-101. PubMed ID: 21616448
[TBL] [Abstract][Full Text] [Related]
2. Combined androgen blockade: the gold standard for metastatic prostate cancer.
McLeod DG; Crawford ED; DeAntoni EP
Eur Urol; 1997; 32 Suppl 3():70-7. PubMed ID: 9267789
[TBL] [Abstract][Full Text] [Related]
3. Endocrine treatment of prostate cancer.
Tammela T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
[TBL] [Abstract][Full Text] [Related]
4. [Hormone therapy of locally advanced and metastatic prostate carcinoma].
Rübben H
Praxis (Bern 1994); 2001 Sep; 90(38):1641-4. PubMed ID: 11675917
[TBL] [Abstract][Full Text] [Related]
5. Secondary hormonal manipulations in the management of advanced prostate cancer.
Chaudhary UB; Rashid MH; Onitilo AA; Bissada NK
Can J Urol; 2005 Jun; 12(3):2666-76. PubMed ID: 16011813
[TBL] [Abstract][Full Text] [Related]
6. Secondary hormonal therapy for advanced prostate cancer.
Lam JS; Leppert JT; Vemulapalli SN; Shvarts O; Belldegrun AS
J Urol; 2006 Jan; 175(1):27-34. PubMed ID: 16406864
[TBL] [Abstract][Full Text] [Related]
7. New agents and strategies for the hormonal treatment of castration-resistant prostate cancer.
Sharifi N
Expert Opin Investig Drugs; 2010 Jul; 19(7):837-46. PubMed ID: 20524793
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the use of early hormonal therapy in patients with localised or locally advanced prostate cancer.
Kaisary AV
Prostate Cancer Prostatic Dis; 2005; 8(2):140-51. PubMed ID: 15852051
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer: the role of hormonal therapy.
Salesi N; Carlini P; Ruggeri EM; Ferretti G; Bria E; Cognetti F
J Exp Clin Cancer Res; 2005 Jun; 24(2):175-80. PubMed ID: 16110748
[TBL] [Abstract][Full Text] [Related]
10. [Management of a hormone dependent cancer with endocrine therapy--prostate cancer].
Tsukamoto S; Akaza H
Gan To Kagaku Ryoho; 2001 Jul; 28(7):917-26. PubMed ID: 11478140
[TBL] [Abstract][Full Text] [Related]
11. [Hormonal therapy in metastatic prostatic cancer].
Ruffion A; Fontaine E; Staerman F
Prog Urol; 2003 Apr; 13(2):334-41. PubMed ID: 12765081
[TBL] [Abstract][Full Text] [Related]
12. Intermittent androgen suppression for locally advanced and metastatic prostate cancer: preliminary report of a prospective multicenter study.
Sato N; Akakura K; Isaka S; Nakatsu H; Tanaka M; Ito H; Masai M;
Urology; 2004 Aug; 64(2):341-5. PubMed ID: 15302491
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic options in advanced cancer of the prostate].
Schmid HP; Bitton A
Praxis (Bern 1994); 1997 Oct; 86(44):1734-9. PubMed ID: 9446174
[TBL] [Abstract][Full Text] [Related]
14. [Keyrole of endocrinology in the victory against prostate cancer].
Labrie F
Bull Cancer; 2006 Sep; 93(9):949-58. PubMed ID: 16980238
[TBL] [Abstract][Full Text] [Related]
15. Current treatment of advanced prostate cancer.
Ismail M; Gomella LG
Tech Urol; 1997; 3(1):16-24. PubMed ID: 9170220
[TBL] [Abstract][Full Text] [Related]
16. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
Suzuki H; Okihara K; Miyake H; Fujisawa M; Miyoshi S; Matsumoto T; Fujii M; Takihana Y; Usui T; Matsuda T; Ozono S; Kumon H; Ichikawa T; Miki T;
J Urol; 2008 Sep; 180(3):921-7. PubMed ID: 18635218
[TBL] [Abstract][Full Text] [Related]
17. Gn-RH antagonist possible response, after Gn-RH agonist failure in a man with metastatic prostate cancer.
Rocco B; Ferrari M; Scardino E; Matei DV; Verweij F; Varela R; De Cobelli O
Anticancer Res; 2005; 25(1B):577-8. PubMed ID: 15816630
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum progastrin-releasing peptide (31-98) level is a predictor of short response duration after hormonal therapy in metastatic prostate cancer.
Yashi M; Nukui A; Kurokawa S; Ochi M; Ishikawa S; Goto K; Kobayashi Y; Muraishi O; Tokue A
Prostate; 2003 Sep; 56(4):305-12. PubMed ID: 12858359
[TBL] [Abstract][Full Text] [Related]
19. Optimal hormonal therapy for advanced prostatic carcinoma.
Goktas S; Crawford ED
Semin Oncol; 1999 Apr; 26(2):162-73. PubMed ID: 10597727
[TBL] [Abstract][Full Text] [Related]
20. [Early versus late hormonal treatment in advanced prostate cancer].
Allepuz Losa C; Gil Martínez P; Gil Sanz MJ; Rioja Sanz LA
Actas Urol Esp; 1999; 23(7):557-64. PubMed ID: 10488608
[No Abstract] [Full Text] [Related]
[Next] [New Search]
